Patents by Inventor Nathan Dormer

Nathan Dormer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12036323
    Abstract: Novel microsphere compositions for use in parenteral formulations are provided. The microspheres comprise a biodegradable polymer of a molecular weight greater than 10,000 daltons, an active therapeutic agent, and a cellulose-derived material such as ethyl cellulose, carboxymethyl cellulose, hydroxypropylmethyl cellulose, or sodium carboxymethyl cellulose. The microsphere compositions decreased deviation in mean microsphere diameter, improved drug entrapment, and improved microsphere stability.
    Type: Grant
    Filed: June 28, 2023
    Date of Patent: July 16, 2024
    Assignee: ADARE PHARMACEUTICALS USA, INC.
    Inventors: Nathan Dormer, Cory Berkland
  • Publication number: 20230338292
    Abstract: Novel microsphere compositions for use in parenteral formulations are provided. The microspheres comprise a biodegradable polymer of a molecular weight greater than 10,000 daltons, an active therapeutic agent, and a cellulose-derived material such as ethyl cellulose, carboxymethyl cellulose, hydroxypropylmethyl cellulose, or sodium carboxymethyl cellulose. The microsphere compositions decreased deviation in mean microsphere diameter, improved drug entrapment, and improved microsphere stability.
    Type: Application
    Filed: June 28, 2023
    Publication date: October 26, 2023
    Inventors: Nathan DORMER, Cory BERKLAND
  • Patent number: 11723868
    Abstract: Novel microsphere compositions for use in parenteral formulations are provided. The microspheres comprise a biodegradable polymer of a molecular weight greater than 10,000 daltons, an active therapeutic agent, and a cellulose-derived material such as ethyl cellulose, carboxymethyl cellulose, hydroxypropylmethyl cellulose, or sodium carboxymethyl cellulose. The microsphere compositions decreased deviation in mean microsphere diameter, improved drug entrapment, and improved microsphere stability.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: August 15, 2023
    Assignee: Adare Pharmaceuticals USA, Inc.
    Inventors: Nathan Dormer, Cory Berkland
  • Publication number: 20230248654
    Abstract: Swellable oral compositions are described which, upon addition of water, form semi-solid products prior to administration. The compositions are particularly suitable for administration to subjects who may have difficulty in, or a dislike for, swallowing solid oral compositions, such as tablets and capsules.
    Type: Application
    Filed: July 12, 2021
    Publication date: August 10, 2023
    Inventors: Nathan DORMER, Michelle K. SCHILLING, Jeffrey OVERFIELD
  • Publication number: 20220273674
    Abstract: An extended-release drug delivery composition and method of administering the same is provided. The composition comprises microspheres loaded with a biologically-active agent and suspended in a soluble polymer capable of forming a film upon injection onto a biological surface.
    Type: Application
    Filed: May 16, 2022
    Publication date: September 1, 2022
    Inventors: Nathan DORMER, Cory BERKLAND
  • Publication number: 20210077404
    Abstract: Novel microsphere compositions for use in parenteral formulations are provided. The microspheres comprise a biodegradable polymer of a molecular weight greater than 10,000 daltons, an active therapeutic agent, and a cellulose-derived material such as ethyl cellulose, carboxymethyl cellulose, hydroxypropylmethyl cellulose, or sodium carboxymethyl cellulose. The microsphere compositions decreased deviation in mean microsphere diameter, improved drug entrapment, and improved microsphere stability.
    Type: Application
    Filed: November 24, 2020
    Publication date: March 18, 2021
    Inventors: Nathan DORMER, Cory BERKLAND
  • Patent number: 10874612
    Abstract: Novel microsphere compositions for use in parenteral formulations are provided. The microspheres comprise a biodegradable polymer of a molecular weight greater than 10,000 daltons, an active therapeutic agent, and a cellulose-derived material such as ethyl cellulose, carboxymethyl cellulose, hydroxypropylmethyl cellulose, or sodium carboxymethyl cellulose. The microsphere compositions decreased deviation in mean microsphere diameter, improved drug entrapment, and improved microsphere stability.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: December 29, 2020
    Assignee: Adare Pharmaceuticals USA, Inc.
    Inventors: Nathan Dormer, Cory Berkland
  • Publication number: 20190216825
    Abstract: An extended-release drug delivery composition and method of administering the same is provided. The composition comprises microspheres loaded with a biologically-active agent and suspended in a soluble polymer capable of forming a film upon injection onto a biological surface.
    Type: Application
    Filed: March 20, 2019
    Publication date: July 18, 2019
    Inventors: Nathan Dormer, Cory Berkland
  • Patent number: 10238663
    Abstract: An extended-release drug delivery composition and method of administering the same is provided. The composition comprises microspheres loaded with a biologically-active agent and suspended in a soluble polymer capable of forming a film upon injection onto a biological surface.
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: March 26, 2019
    Assignee: ORBIS BIOSCIENCES, INC.
    Inventors: Nathan Dormer, Cory Berkland
  • Publication number: 20190060238
    Abstract: Novel microsphere compositions for use in parenteral formulations are provided. The microspheres comprise a biodegradable polymer of a molecular weight greater than 10,000 daltons, an active therapeutic agent, and a cellulose-derived material such as ethyl cellulose, carboxymethyl cellulose, hydroxypropylmethyl cellulose, or sodium carboxymethyl cellulose. The microsphere compositions decreased deviation in mean microsphere diameter, improved drug entrapment, and improved microsphere stability.
    Type: Application
    Filed: October 26, 2018
    Publication date: February 28, 2019
    Inventors: Nathan Dormer, Cory Berkland
  • Publication number: 20170304320
    Abstract: An extended-release drug delivery composition and method of administering the same is provided. The composition comprises microspheres loaded with a biologically-active agent and suspended in a soluble polymer capable of forming a film upon injection onto a biological surface.
    Type: Application
    Filed: July 7, 2017
    Publication date: October 26, 2017
    Inventors: Nathan Dormer, Cory Berkland
  • Publication number: 20150359804
    Abstract: An extended-release drug delivery composition and method of administering the same is provided. The composition comprises microspheres loaded with a biologically-active agent and suspended in a soluble polymer capable of forming a film upon injection onto a biological surface.
    Type: Application
    Filed: June 12, 2015
    Publication date: December 17, 2015
    Inventors: Nathan Dormer, Cory Berkland